Mayne Pharma Group Ltd. | Balance Sheet
Fiscal year is July-June. All values AUD Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
16
61
51
71
103
Total Accounts Receivable
31
68
100
234
275
Inventories
17
22
39
106
82
Other Current Assets
2
5
888
11
21
Total Current Assets
66
157
1,077
422
481
Net Property, Plant & Equipment
53
60
84
189
230
Total Investments and Advances
4
-
-
-
-
Intangible Assets
141
303
332
1,235
1,055
Total Assets
273
537
1,544
1,928
1,846
ST Debt & Current Portion LT Debt
-
2
-
1
13
Accounts Payable
7
52
64
67
64
Income Tax Payable
-
2
12
-
-
Other Current Liabilities
20
42
947
113
116
Total Current Liabilities
30
95
1,024
193
180
Long-Term Debt
46
62
76
327
374
Provision for Risks & Charges
1
1
1
2
2
Deferred Taxes
20
32
10
4
31
Other Liabilities
7
7
6
17
5
Total Liabilities
113
215
1,167
615
611
Common Equity (Total)
159
311
364
1,304
1,226
Total Shareholders' Equity
159
311
364
1,304
1,226
Total Equity
159
322
376
1,312
1,235
Liabilities & Shareholders' Equity
273
537
1,544
1,928
1,846
Accumulated Minority Interest
-
11
12
9
9
About Mayne Pharma Group
View Profile
